Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register
- PMID: 24002670
- DOI: 10.1177/1479164113500798
Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register
Abstract
Objective: Reduced renal function and albuminuria predict cardiovascular (CV) events and mortality in type 2 diabetes (T2D). In addition, we evaluated the role of co-existing congestive heart failure (CHF) and other CV risk factors on CV events in a large observational population-based cohort of T2D patients.
Research design and methods: We included 66,065 patients with T2D who were reported to the National Diabetes Register (NDR) in Sweden between 2003-2006 with a follow-up of 5.7 years. Data on outcomes were collected from the cause of death and hospital discharge registers.
Results: A total of 10% of patients experienced a CV event and 3.7% of these were fatal. Increasing levels of albuminuria and renal impairment were independently associated with increasing risk of CV events and all-cause mortality also when adjusting for CHF. In normoalbuminuric patients, a reduction in renal function is an important predictor of CV events and all-cause mortality. Glycaemic control (high HbA1c), smoking and hyperlipidaemia had important effects on risk for CV events in patients with albuminuria, while high blood pressure, but not glycaemic control, had an effect in patients with normoalbuminuric renal impairment.
Conclusion: Albuminuria and renal impairment are independent risk factors for CV outcomes and mortality in T2D, albuminuria being the strongest risk factor and relevant at all levels of renal function. In normoalbuminuric patients, a reduction in renal function is an important predictor of CV events and all-cause mortality.
Keywords: Type 2 diabetes; albuminuria; cardiovascular disease; congestive heart failure; epidemiology and outcomes; renal function.
Similar articles
-
Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.J Diabetes Complications. 2013 May-Jun;27(3):229-34. doi: 10.1016/j.jdiacomp.2012.10.010. Epub 2012 Dec 12. J Diabetes Complications. 2013. PMID: 23246248
-
Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).Nephrol Dial Transplant. 2011 Apr;26(4):1236-43. doi: 10.1093/ndt/gfq535. Epub 2010 Sep 3. Nephrol Dial Transplant. 2011. PMID: 20817668
-
Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register.Diab Vasc Dis Res. 2017 May;14(3):226-235. doi: 10.1177/1479164116683637. Epub 2017 Feb 1. Diab Vasc Dis Res. 2017. PMID: 28467201
-
[Diabetes and kidneys].Dtsch Med Wochenschr. 2013 May;138(18):949-55. doi: 10.1055/s-0032-1332992. Epub 2013 Apr 23. Dtsch Med Wochenschr. 2013. PMID: 23613374 Review. German.
-
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria.Kidney Int Suppl. 2004 Nov;(92):S50-5. doi: 10.1111/j.1523-1755.2004.09213.x. Kidney Int Suppl. 2004. PMID: 15485418 Review.
Cited by
-
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators.J Diabetes Investig. 2024 Aug;15(8):1151-1160. doi: 10.1111/jdi.14222. Epub 2024 Apr 27. J Diabetes Investig. 2024. PMID: 38676417 Free PMC article.
-
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis.Commun Med (Lond). 2024 Jan 22;4(1):11. doi: 10.1038/s43856-023-00429-z. Commun Med (Lond). 2024. PMID: 38253823 Free PMC article.
-
Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States.Am J Prev Cardiol. 2023 Nov 12;16:100604. doi: 10.1016/j.ajpc.2023.100604. eCollection 2023 Dec. Am J Prev Cardiol. 2023. PMID: 38162437 Free PMC article.
-
Clinical Profile of Nonproteinuric Kidney Disease in Type 2 Diabetic Patients in India.Indian J Nephrol. 2023 Jul-Aug;33(4):283-288. doi: 10.4103/ijn.ijn_54_22. Epub 2023 Apr 4. Indian J Nephrol. 2023. PMID: 37781550 Free PMC article.
-
Deficiencies in the Recognition and Reporting of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus; A Hungarian Nationwide Analysis.Int J Public Health. 2023 Aug 29;68:1606151. doi: 10.3389/ijph.2023.1606151. eCollection 2023. Int J Public Health. 2023. PMID: 37705761 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical